1-4 of 4
Bo Dai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting HDAC3 to Overcome the Resistance to ATRA or Arsenic in Acute Promyelocytic Leukemia through Ubiquitination and Degradation of PML-RARα

Bo Dai, Feng Wang, Ying Wang, Jiayan Zhu, Yunxuan Li, Tingting Zhang, Luyao Zhao, Li-Ling Wang, Wenhui GAO, Junmin Li, Aibin Liang, Hong-hu Zhu, Ke Li, Jiong Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 5924–5925.
https://doi.org/10.1182/blood-2022-156735
Published: 2022
Journal Articles

Mutation in Wilms' Tumor 1 Induces DNA Hypermethylation of PRC2 Targets, Blocks Myelomonocytic Differentiation, and Defines a Novel Subtype of AML Responsive to EZH2 Inhibition

Daniel Thomas, MD PhD, Subarna Sinha, PhD, Linda Yu, Namyoung Jung, BS, Bo Dai, PhD, Andrew J Gentles, PhD, Andrew P. Feinberg, MD, David Dill, PhD, Ravindra Majeti, MD PhD
Journal: Blood
Blood (2014) 124 (21): 780.
https://doi.org/10.1182/blood.V124.21.780.780
Published: 2014
Journal Articles

Epigenetic Signature of Leukemia Stem Cells Defines Subgroups Associated with Clinical Outcome and Cell of Origin in AML

Namyoung Jung, BS, Bo Dai, PhD, Andrew J. Gentles, PhD, Peter Murakami, MSc, Ravindra Majeti, MD PhD, Andrew P. Feinberg, MD
Journal: Blood
Blood (2014) 124 (21): 2147.
https://doi.org/10.1182/blood.V124.21.2147.2147
Published: 2014
Journal Articles

Genome-Wide Characterization of Human Hematopoietic Progenitor Cell Heterogeneity by Expression Profiling of Single Cells: A Pilot Study

Chih Long Liu, Ph.D., Bo Dai, Ph.D., Aaron M. Newman, PhD, Ravi Majeti, MD, PhD, Ash A Alizadeh, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1231.
https://doi.org/10.1182/blood.V120.21.1231.1231
Published: 2012